Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY 14642, USA.
Cell Rep. 2012 Sep 27;2(3):580-90. doi: 10.1016/j.celrep.2012.08.011. Epub 2012 Sep 13.
The ABCA1 protein mediates the transfer of cellular cholesterol across the plasma membrane to apolipoprotein A-I. Loss-of-function mutations in the ABCA1 gene induce Tangier disease and familial hypoalphalipoproteinemia, both cardiovascular conditions characterized by abnormally low levels of serum cholesterol, increased cholesterol in macrophages, and subsequent formation of vascular plaque. Increased intracellular cholesterol levels are also frequently found in cancer cells. Here, we demonstrate anticancer activity of ABCA1 efflux function, which is compromised following inhibition of ABCA1 gene expression by oncogenic mutations or cancer-specific ABCA1 loss-of-function mutations. In concert with elevated cholesterol synthesis found in cancer cells, ABCA1 deficiency allows for increased mitochondrial cholesterol, inhibits release of mitochondrial cell death-promoting molecules, and thus facilitates cancer cell survival, suggesting that elevated mitochondrial cholesterol is essential to the cancer phenotype.
ABCA1 蛋白介导细胞胆固醇穿过质膜向载脂蛋白 A-I 的转移。ABCA1 基因的功能丧失突变会引起 Tangier 病和家族性低α脂蛋白血症,这两种心血管疾病的特征是血清胆固醇水平异常低、巨噬细胞中的胆固醇增加,以及随后形成血管斑块。癌细胞中也经常发现细胞内胆固醇水平升高。在这里,我们证明了 ABCA1 外排功能的抗癌活性,这种活性在致癌突变或癌症特异性 ABCA1 功能丧失突变抑制 ABCA1 基因表达后受到损害。与癌细胞中发现的升高的胆固醇合成一致,ABCA1 缺乏允许增加线粒体胆固醇,抑制线粒体细胞死亡促进分子的释放,从而促进癌细胞存活,表明升高的线粒体胆固醇对癌症表型是必需的。